Health care merger places Hawaiʻi's well-being at risk.
The Queen’s Medical Center
Neuroscience Institute Outpatient Center
Physicians Office Building 3 (POB3)
550 South Beretania Street
Suite 405
Honolulu, Hawaii 96813
Phone:
808-691-8866
Fax:
808-691-8865
Hours:
Monday – Friday, 8am – 4:30pm
The Queen’s Neuroscience Institute offers care for patients with multiple sclerosis (MS) and other inflammatory disorders affecting the central nervous system. Our Center provides focused care dedicated to the comprehensive diagnosis and treatment of neuroinflammatory disorders. We treat patients of all ages, ranging from pediatrics to elderly patients, including specialized considerations for women of childbearing age.
We are proud to collaborate with the National Multiple Sclerosis Society as a designated Partner in MS Care, providing expert, specialized care for individuals living with multiple sclerosis—both locally in Hawai‘i and across the nation. As the first and only health care system in Hawai‘i to receive this distinction, we serve not only as a trusted care provider but also as a valuable resource for education and support for patients, families, and health care professionals.
Multiple Sclerosis is a disease of the central nervous system mediated by impairments in immune function. MS causes destruction of myelin, the insulation surrounding the nerve fibers in the brain and spinal cord. This leads to slowing of signal transmission through the central nervous system and causes a variety of symptoms including weakness, numbness, bladder/bowel symptoms, imbalance, fatigue, heat sensitivity, mood disturbance, and cognitive slowing. There is no one test to determine MS. The diagnosis of MS is based on clinical symptoms, MRI results, and sometimes electrophysiologic and cerebrospinal fluid analyses.
Neuroinflammatory disorders include a wide range of neurologic illness caused by autoimmune or inflammatory processes. These include, but are not limited to:
Diagnostic evaluation: we offer diagnostic testing for evaluation of neuroinflammatory disorders including MRI, lumbar puncture, visual evoked potential, and somatosensory evoked potential testing.
Focused medication management: there are over 25 FDA-approved medications for multiple sclerosis and other neuroinflammatory disorders. There are benefits and risks of each of these therapies, and complex decision-making on medical interventions is provided.
Multidisciplinary care: many patients with neuroinflammatory disorders experience symptoms of spasticity (muscle tightness), bladder/bowel symptoms, weakness, pain, and cognitive impairment. We prioritize the treatment and optimization of these symptoms to improve quality of life. In addition to medication management, we serve as a liason with other specialists including urologists, rehabilitation services, neuropsychologists, and social workers to provide excellent, comprehensive care.
Back to Top
